TRAUPA: Study of Affective Forecasting Skills in Post-traumatic Stress Disorder

Sponsor
University Hospital, Lille (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05268965
Collaborator
(none)
108
24

Study Details

Study Description

Brief Summary

Post-traumatic stress disorder (PTSD) is associated with a marked tendency to have exaggerated and persistent negative beliefs and expectations about oneself or the world . Although posttraumatic stress symptoms have been shown to be associated with a tendency to negatively anticipate the future, affective forecasting skills (i.e., the ability to predict one's own emotional reactions in response to a future event) have never been explored in PTSD . The hypothesis that the PTSD is associated with a negative affective forecasting bias, characterized by a tendency to predict more intense emotional responses to future negative events.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Experimental: group comparison

Study Design

Study Type:
Observational
Anticipated Enrollment :
108 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Autonomic and Subjective Correlates of Affective Forecasting Skills in Post-traumatic Stress Disorder
Anticipated Study Start Date :
Apr 1, 2022
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Patients meeting DSM-5 criteria for PTSD.

Behavioral: Experimental: group comparison
Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI) State-Trait-Anxiety Inventory (Spielberger, 1993) Beck Depression Inventory (BDI-II, 1998) Cognitive Emotional Regulation Questionnaire (Jermann & al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality) Task / affective forecasting: Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios Step 2: experience of the same scenarios in virtual reality

Group 2: Healthy controls who experienced a traumatic event but did not meet DSM-5 criteria for PTSD

Behavioral: Experimental: group comparison
Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI) State-Trait-Anxiety Inventory (Spielberger, 1993) Beck Depression Inventory (BDI-II, 1998) Cognitive Emotional Regulation Questionnaire (Jermann & al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality) Task / affective forecasting: Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios Step 2: experience of the same scenarios in virtual reality

Group 3: Healthy controls who did not experience a traumatic event

Behavioral: Experimental: group comparison
Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI) State-Trait-Anxiety Inventory (Spielberger, 1993) Beck Depression Inventory (BDI-II, 1998) Cognitive Emotional Regulation Questionnaire (Jermann & al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality) Task / affective forecasting: Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios Step 2: experience of the same scenarios in virtual reality

Outcome Measures

Primary Outcome Measures

  1. difference of arousal assessments measured using the Self-Assessment Manikin between the prediction and emotional experience phases [During the experimental task (2 hours)]

    To compare the subjective affective forecasting bias between the PTSD group and the two control groups

Secondary Outcome Measures

  1. subjective correlates of the affective forecasting bias associated with PTSD changes in: valence scores. [During the experimental task (2 hours)]

    valence scores using the Self-Assessment Manikin (Likert-type scale ranging from 1 [very unpleasant] to 9 [very pleasant])

  2. autonomic correlates of the affective prediction bias associated with PTSD: changes in the skin conductance response and heart rate. [During the experimental task (2 hours)]

    changes in the skin conductance response and heart rate assessed using a BIOPAC (System, inc).

  3. link between PTSD symptomatology and affective forecasting bias [During the experimental task (2 hours)]

    PTSD symptomatology assessed using the Clinician-Administered PTSD Scale (CAPS-5) and PTSD Checklist for DSM-5 (PCL-5)

  4. link and correlation coefficients between biases measured at the neurovegetative (changes in heart rate and skin conductance) and subjective levels (arousal and valence ratings from the Self-Assessment Manikin) in PTSD [During the experimental task (2 hours)]

  5. link and correlation coefficients between affective forecasting bias and emotion regulation skills within each group [During the experimental task (2 hours)]

    affective forecasting bias and emotion regulation skills, assessed using the Cognitive Emotional Regulation Questionnaire (CERQ)

  6. link and correlation coefficients between affective forecasting bias and anxiety and depression [During the experimental task (2 hours)]

    anxiety and depression, respectively assessed using the State-Trait-Anxiety Inventory (STAI) and the Beck Depression Inventory (BDI-II), within each group

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Understanding and being able to express themselves in French

  • Understanding of informed consent and signature of the study participation form

  • Giving informed, dated and signed consent

  • Benefiting from health insurance coverage

  • Normal or corrected visual and auditory acuity to achieve normality

  • Group 1 : DSM-5 PTSD criteria, assessed using CAPS and PTSD Checklist for DSM-5 (PCL-5, Weathers & al., 2013)

  • Group 2: PTSD Criteria A only

Exclusion Criteria:

Refusal of participation after clear and fair information on the study.

  • Visual or auditory sensory disability to participate in the study.

  • Personal history of neurological disease or current neurological disease.

  • Personal history of current psychiatric disorder or psychiatric disorder (excluding PTSD in patients in the experimental group), assessed via the MINI.

  • Pregnant or breastfeeding women

  • Consumption of toxic substances other than tobacco and alcohol.

  • Minors or adults under guardianship, under judicial protection, persons deprived of liberty.

  • Groups 2 and 3: personal history of psychiatric disorder or current psychiatric disorder and taking psychotropic drugs

  • Group 1: personal history of psychiatric disorders or current psychiatric disorders other than anxiety, depressive, trauma and stress-related disorders and treatment with psychotropic drugs not stabilized

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Lille

Investigators

  • Principal Investigator: Guillaume Vaiva, MD,PhD, University Hospital, Lille

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Lille
ClinicalTrials.gov Identifier:
NCT05268965
Other Study ID Numbers:
  • 2021_0385
  • 2021-A01582-39
First Posted:
Mar 7, 2022
Last Update Posted:
Mar 7, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Lille
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 7, 2022